131 – 140 of 304
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
Identification of SPARC-like 1 Protein as Part of a Biomarker Panel for Alzheimer's Disease in Cerebrospinal Fluid
(
- Contribution to journal › Article
-
Mark
Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and/or Parkinsonian Disorders
(
- Contribution to journal › Article
-
Mark
The association between white matter hyperintensities and executive decline in mild cognitive impairment is network dependent
(
- Contribution to journal › Article
-
Mark
Safety, tolerability, and antibody response of active A beta immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study
(
- Contribution to journal › Article
-
Mark
Cerebrospinal Fluid Levels of β-Amyloid 1-42, but Not of Tau, Are Fully Changed Already 5 to 10 Years Before the Onset of Alzheimer Dementia.
(
- Contribution to journal › Article
-
Mark
Test sequence of CSF and MRI biomarkers for prediction of AD in subjects with MCI
(
- Contribution to journal › Article
-
Mark
CSF Biomarkers Correlate with Cerebral Blood Flow on SPECT in Healthy Elderly.
(
- Contribution to journal › Article
-
Mark
Amyloid-beta Oligomers in Cerebrospinal Fluid are Associated with Cognitive Decline in Patients with Alzheimer's Disease
(
- Contribution to journal › Article
-
Mark
Body mass index is associated with biological CSF markers of core brain pathology of Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Altered CSF Orexin and α-Synuclein Levels in Dementia Patients.
(
- Contribution to journal › Article